Demonstration of type II latency in T lymphocytes of Epstein-Barr Virus-associated hemophagocytic lymphohistiocytosis

Pediatric Blood and Cancer

Volumn 60, Issue 2, 2013, Pages 326-328

  Ito, Yoshinori ^a   Kawamura, Yoshiki ^b   Iwata, Seiko ^a   Kawada, Jun ichi ^a   Yoshikawa, Tetsushi ^b   Kimura, Hiroshi ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Epstein Barr virus; Hemophagocytic lymphohistiocytosis; T lymphocyte

Indexed keywords

ASPARTATE AMINOTRANSFERASE; CD5 ANTIGEN; CYCLOSPORIN A; DEXAMETHASONE; DNA; EPSTEIN BARR VIRUS ANTIGEN; EPSTEIN BARR VIRUS ANTIGEN 1; EPSTEIN BARR VIRUS ANTIGEN 2; FERRITIN; HEMOGLOBIN; HLA DR ANTIGEN; IMMUNOGLOBULIN G; INTERLEUKIN 2 RECEPTOR; LACTATE DEHYDROGENASE; LATENT MEMBRANE PROTEIN 1;

ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ASPIRATION; CASE REPORT; CD8+ T LYMPHOCYTE; CERVICAL LYMPH NODE; CHILD; EPSTEIN BARR VIRUS; ERYTHROPHAGOCYTOSIS; FEVER; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; HEMOPHAGOCYTIC SYNDROME; HEPATOSPLENOMEGALY; HISTIOCYTE; HODGKIN DISEASE; HUMAN; HYPERTRIGLYCERIDEMIA; HYPOFIBRINOGENEMIA; IMMUNE DYSREGULATION; LACTATE DEHYDROGENASE BLOOD LEVEL; LEUKOCYTE; MALE; NASOPHARYNX CARCINOMA; NEUTROPHIL; PANCYTOPENIA; PERIPHERAL BLOOD MONONUCLEAR CELL; PHYSICAL EXAMINATION; PRESCHOOL CHILD; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SWELLING; T LYMPHOCYTE; THROMBOCYTE; VIRUS CAPSID; VIRUS LATENCY;

CD8-POSITIVE T-LYMPHOCYTES; CHILD; EPSTEIN-BARR VIRUS INFECTIONS; FLOW CYTOMETRY; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MALE; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84871109356     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.24319     Document Type: Article

References (13)

1. Henter JI, Horne A, Arico M, et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007; 48: 124-131.
2. Rouphael NG, Talati NJ, Vaughan C, et al. Infections associated with haemophagocytic syndrome. Lancet Infect Dis 2007; 7: 814-822.
3. Cohen JI. Epstein-Barr virus infection. N Engl J Med 2000; 343: 481-492.
4. Quintanilla-Martinez L, Kumar S, Fend F, et al. Fulminant EBV(+) T-cell lymphoproliferative disorder following acute/chronic EBV infection: A distinct clinicopathologic syndrome. Blood 2000; 96: 443-451.
5. Kasahara Y, Yachie A, Takei K, et al. Differential cellular targets of Epstein-Barr virus (EBV) infection between acute EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection. Blood 2001; 98: 1882-1888.
6. Wada T, Kurokawa T, Toma T, et al. Immunophenotypic analysis of Epstein-Barr virus (EBV)-infected CD8(+) T cells in a patient with EBV-associated hemophagocytic lymphohistiocytosis. Eur J Haematol 2007; 79: 72-75.
7. Lin MT, Chang HM, Huang CJ, et al. Massive expansion of EBV+ monoclonal T cells with CD5 down regulation in EBV-associated haemophagocytic lymphohistiocytosis. J Clin Pathol 2007; 60: 101-103.
8. Toga A, Wada T, Sakakibara Y, et al. Clinical significance of cloned expansion and CD5 down-regulation in Epstein-Barr Virus (EBV)-infected CD8+ T lymphocytes in EBV-associated hemophagocytic lymphohistiocytosis. J Infect Dis 2010; 201: 1923-1932.
9. Kimura H, Miyake K, Yamauchi Y, et al. Identification of Epstein-Barr virus (EBV)-infected lymphocyte subtypes by flow cytometric in situ hybridization in EBV-associated lymphoproliferative diseases. J Infect Dis 2009; 200: 1078-1087.
10. Iwata S, Wada K, Tobita S, et al. Quantitative analysis of Epstein-Barr virus (EBV)-related gene expression in patients with chronic active EBV infection. J Gen Virol 2010; 91: 42-50.
11. Hoelzer D, Gokbuget N. Chemoimmunotherapy in acute lymphoblastic leukemia. Blood Rev 2012; 26: 25-32.
12. Ishida T, Ueda R. Immunopathogenesis of lymphoma: focus on CCR4. Cancer Sci 2011; 102: 44-50.
13. Sugaya N, Kimura H, Hara S, et al. Quantitative analysis of Epstein-Barr virus (EBV)-specific CD8+ T cells in patients with chronic active EBV infection. J Infect Dis 2004; 190: 985-988.